Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
DAY ONE BIOPHARMACEUTICALS I
About DAWN
Day One Biopharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing targeted therapies for people of all ages with life-threatening diseases. It partners with clinical oncologists, families, and scientists to identify, acquire, and develop cancer treatments. Its commercial product, OJEMDA (tovorafenib), is an oral, brain-penetrant, selective type II rapidly accelerated fibrosarcoma (RAF) kinase inhibitor. OJEMDA is used for the treatment of patients over six months of age and older with relapsed or refractory pLGG harboring a BRAF fusion or rearrangement, or BRAF V600 mutation. Its pipeline product candidates include DAY301 and Emi-Le (emiltatug ledadotin). DAY301 is a novel Antibody Drug Conjugate, or ADC, targeting protein-tyrosine kinase 7, or PTK7. Emi-Le (emiltatug ledadotin) is a novel antibody drug conjugate (ADC) targeting the B7-H4 protein in clinical development to treat the rare cancer adenoid cystic carcinoma (ACC).
Find out what a historical investment in DAY ONE BIOPHARMACEUTICALS I would be worth today using our DAWN stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy DAWN shares in Australia?
Buying DAWN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in DAY ONE BIOPHARMACEUTICALS I in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in DAWN
What is the ticker symbol of DAY ONE BIOPHARMACEUTICALS I?
The ticker symbol for DAY ONE BIOPHARMACEUTICALS I is DAWN.
How much is one share of DAWN?
One share of DAWN is valued at $21.53 as of 20 May 2026.
What is the market capitalisation of DAY ONE BIOPHARMACEUTICALS I DAWN?
As of 20 May 2026 DAY ONE BIOPHARMACEUTICALS I has a market cap of -.
What is the 52-week high for DAY ONE BIOPHARMACEUTICALS I stock?
The DAY ONE BIOPHARMACEUTICALS I 52-week high stock price is $NaN.
What is the 52-week low for DAY ONE BIOPHARMACEUTICALS I stock?
The DAY ONE BIOPHARMACEUTICALS I 52-week low stock price is $NaN.
Can I buy DAWN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy DAWN shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in DAWN on Stake
- Buy DAWN from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of DAWN from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
DAWN related stocks